Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is capable of large‐scale
transmission and has caused the coronavirus disease 2019 (COVID‐19) pandemic. Patients …

Passive immunotherapeutics (PITs), including convalescent plasma, serum, or
hyperimmune immunoglobulin, have been of clinical importance during sudden outbreaks …

The coronavirus disease 2019 (COVID-19) pandemic has left the world in a state of
desolation with overburdening public health systems in a short period. Finding possible …

Background In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐
2) virus emerged in China and quickly spread into a worldwide pandemic. Prior to the …

Blood from people who have recovered can be a rich source of antibodies, proteins made by
the immune system to attack the virus. The part of the blood that contains antibodies, so …

Convalescent plasma and/or hyperimmune globulin have been used as means of providing
passive immunity in several notable viral outbreaks. Early in the coronavirus disease 2019 …

Abstract Coronavirus disease 2019 (COVID‐19) remains a global public health threat.
Hence, more effective and specific antivirals are urgently needed. Here, COVID‐19 …

As of early 2020, humanity is confronting a pandemic in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes coronavirus disease, abbreviated as …

Background Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐infected
patients exhibit disease ranging from asymptomatic to severe pneumonia, multi‐organ …

Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …